BBA
KYMR icon

Baker Bros. Advisors’s Kymera Therapeutics KYMR Stock Holding History

Baker Bros. Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$993M Hold
8,657,242
– – 4.97% 6
2026
Q1 		$721M Hold
8,657,242
– – 4.14% 9
2025
Q4 		$674M Buy
8,657,242
+2,005,813
+30% +$135M 3.94% 8
2025
Q3 		$376M Hold
6,651,429
– – 2.72% 10
2025
Q2 		$290M Buy
6,651,429
+655,500
+11% +$22.6M 2.82% 9
2025
Q1 		$164M Hold
5,995,929
– – 1.82% 9
2024
Q4 		$241M Hold
5,995,929
– – 2.58% 9
2024
Q3 		$284M Buy
5,995,929
+1
+0% +$44 2.94% 9
2024
Q2 		$179M Hold
5,995,928
– – 2.29% 10
2024
Q1 		$241M Hold
5,995,928
– – 3.02% 7
2023
Q4 		$153M Buy
5,995,928
+1,245,528
+26% +$22.3M 1.74% 8
2023
Q3 		$66M Buy
4,750,400
+375,060
+9% +$7.54M 0.38% 19
2023
Q2 		$101M Buy
4,375,340
+1,495,515
+52% +$42.9M 0.58% 15
2023
Q1 		$85.3M Hold
2,879,825
– – 0.46% 13
2022
Q4 		$71.9M Hold
2,879,825
– – 0.43% 17
2022
Q3 		$62.7M Hold
2,879,825
– – 0.41% 23
2022
Q2 		$56.7M Buy
2,879,825
+495,083
+21% +$11.6M 0.32% 21
2022
Q1 		$101M Hold
2,384,742
– – 0.58% 14
2021
Q4 		$151M Hold
2,384,742
– – 0.74% 11
2021
Q3 		$140M Buy
2,384,742
+425,531
+22% +$24.7M 0.62% 15
2021
Q2 		$95M Hold
1,959,211
– – 0.42% 22
2021
Q1 		$76.1M Hold
1,959,211
– – 0.33% 28
2020
Q4 		$121M Hold
1,959,211
– – 0.46% 18
2020
Q3 		$63.3M Buy
+1,959,211
New +$59.8M 0.25% 25

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Baker Bros. Advisors's KYMR Position: Q2 2026 in Review

Baker Bros. Advisors held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 8,657,242 shares worth $993M. The position accounts for 4.97% of the portfolio, ranked #6.

Baker Bros. Advisors first reported a position in KYMR in Q3 2020 and has held it in 24 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Baker Bros. Advisors held 8,657,242 shares of Kymera Therapeutics worth $993M as of Q2 2026.
  • Baker Bros. Advisors left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up 4.97% of Baker Bros. Advisors's portfolio in Q2 2026, its #6 holding.
  • Baker Bros. Advisors first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.